Compare TransMedics Group Inc (TMDX) vs YieldMax Magnificent 7 Fund of Option Income ETFs (YMAG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
TransMedics Group Inc vs YieldMax Magnificent 7 Fund of Option Income ETFs — how do they compare? TransMedics Group Inc trades at $74.3 (market cap $2.54B), while YieldMax Magnificent 7 Fund of Option Income ETFs trades at $11.67. Which is the better fit depends on your goals.
| TMDX | YMAG | |
|---|---|---|
Market Cap | $2.54B | — |
Sector | Technology | Income / Options Overlay |
52-Week High | $150.42 | $15.98 |
52-Week Low | $61.99 | $11.00 |
Enterprise Value | $2.94B | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About TransMedics Group Inc
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →About YieldMax Magnificent 7 Fund of Option Income ETFs
YMAG is an actively managed 'fund of funds' that provides equal-weighted exposure to the seven YieldMax ETFs tracking the 'Magnificent 7' tech giants (Apple, Microsoft, Alphabet, Amazon, Nvidia, Meta, and Tesla). It seeks to generate high current income by harvesting option premiums across these leaders, offering a streamlined way to access concentrated tech volatility in an income-producing format.
Read more on YMAG →
